Prediction: Alphabet Will Be a Larger Company Than Apple by the End of 2027

A Motley Fool analyst predicts Alphabet will surpass Apple to become the world's second-largest company by end of 2027. The prediction is based on Alphabet's aggressive AI investment and faster growth compared to Apple, which has taken a more cautious approach by integrating Google Gemini rather than developing its own AI capabilities. As investor sentiment shifts toward recognizing AI's value, Alphabet's valuation should improve relative to Apple's premium pricing.

10/16/2026, 7:09 PM • The Motley Fool

Stock Market Today, Oct. 16: Tech Stocks Plunge as AI Software Valuations Reverse

Major tech indices declined on October 16, 2026, as AI-focused software stocks experienced a sharp reversal. The S&P 500 fell 1.07%, the Nasdaq Composite plummeted 2.15%, and the Dow Jones slipped 0.34%. Goldman Sachs reported that hedge funds sold AI stocks at the second-fastest pace in over a year, triggering a tactical rotation away from smaller AI names toward larger, steadier companies and defensive stocks.

10/16/2026, 5:49 PM • The Motley Fool

Stock Market Today, Oct. 16: Apple Edges Higher on iPhone Duo Preorder Surge

Apple stock rose 0.43% to $343.46 on October 16, 2026, following strong demand for its new iPhone Duo foldable smartphone, which sold out within minutes with delivery dates pushed to late January. The broader market declined, with the S&P 500 down 1.09% and Nasdaq down 2.14%, as investors focused on AI-related debt pressure and semiconductor weakness.

10/16/2026, 5:29 PM • The Motley Fool

From 2009 to 2026 and Beyond, Apple Has Remained 1 of the Most Valuable Companies in the World: Here's the Most Important Takeaway for Investors

Apple has maintained its position as one of the world's most valuable companies at $5 trillion market cap, trailing only Nvidia. Despite taking a cautious approach to AI infrastructure spending compared to competitors, Apple's strong ecosystem, brand recognition, and iPhone dominance have enabled it to generate exceptional free cash flow of $110 billion while remaining competitive. The article argues Apple's economic moat is wider than perceived and the company can afford to integrate AI gradually without rushing.

10/16/2026, 2:00 PM • The Motley Fool

This Unstoppable Vanguard ETF Could Turn $500 Per Month Into $1 Million Over the Long Term

The Vanguard S&P 500 Growth ETF (VOOG) tracks the S&P 500 Growth index of 151 best-performing growth stocks, heavily weighted toward AI and technology companies. With a 16.9% compound annual return since 2010 and 28.4% over the last three years, consistent $500 monthly investments could potentially reach $1 million in approximately 23 years, even at conservative 14.1% annual returns.

10/16/2026, 9:04 AM • The Motley Fool

Breakfast News: Week in Review

Tech stocks faced headwinds this week as inflation concerns and rising bond yields pressured AI-related companies like Nvidia and Broadcom. CoreWeave's debt spike to $52 billion with 15% bond yields reignited AI debt bubble fears. Despite strong earnings, TSMC, Johnson & Johnson, and Morgan Stanley all sold off, while JPMorgan rallied on solid lending metrics. Consumer spending signals remain mixed, with JPMorgan seeing strength but Domino's warning of economic headwinds. Rocket Lab delayed Neutron's first flight to 2027 due to manufacturing issues. Valuation concerns persist across tech, with ASML, Atlassian, and Klarna highlighting the importance of entry price.

10/16/2026, 7:30 AM • The Motley Fool

Billionaires Are Selling These 6 Artificial Intelligence (AI) Stocks. Should You Follow?

Several billionaire investors sold major AI stocks in Q2, including Apple, Microsoft, Amazon, and Alphabet, citing concerns about AI infrastructure returns and valuations. However, the article advises against simply following these sales, recommending a company-by-company evaluation. Amazon and Apple are highlighted as top picks due to AWS growth and Apple's lower capex exposure to AI, while Tesla is flagged as overvalued given its unproven autonomous technology.

10/16/2026, 5:25 AM • The Motley Fool

SpaceX Has Climbed 15% From Its IPO Price. Here’s Where History Says It Will Be After 1 Year.

SpaceX completed the largest IPO ever four months ago, raising over $85 billion with a trillion-dollar valuation. The stock has climbed 15% from its $135 IPO price after initially surging 50%. Historical analysis of major IPOs suggests SpaceX could experience a double-digit decline within its first year of trading, though the company is delivering strong growth in its Starlink connectivity business and making progress with its Starship rocket program.

10/16/2026, 5:10 AM • The Motley Fool

Warren Buffett's Successor, Greg Abel, Has Over 45% of Berkshire Hathaway's $356 Billion Portfolio Invested in 3 Undeniable Winners

Greg Abel, Warren Buffett's successor as CEO of Berkshire Hathaway, has maintained the company's portfolio concentration strategy with over 45% ($160.6 billion) of invested assets in three major holdings: Apple ($76.73 billion), American Express ($46.72 billion), and Alphabet ($37.17 billion). While Buffett sold 75% of Apple before retirement, Abel views it as a long-term compounder. Abel has significantly increased Berkshire's Alphabet stake, tripling it in Q1 and adding $17 billion in Q2, attracted by Google's search dominance and AI ambitions in Google Cloud.

10/16/2026, 5:06 AM • The Motley Fool

Micron Is Down 23% From Its High. History Suggests This Is What Happens Next.

Micron stock has fallen 23% from its June peak despite reporting exceptional Q4 earnings with 379% revenue growth and 80.7% operating margins. While investors worry about cyclicality in the memory sector, historical analysis shows Micron has recovered from similar drawdowns multiple times over the past decade. The company's strategic customer agreements through 2030, AI-driven demand growth, and $100 billion investment in a new New York megafab suggest this cycle may differ from previous ones.

10/16/2026, 12:30 AM • The Motley Fool

Bitcoin Pizza vs. Apple's Third Co-Founder: Which "Worst Investment Ever" Actually Teaches Investors More?

The article examines two famous investment regrets—the Bitcoin pizza transaction and early Apple shares—to illustrate how early liquidity decisions can erase significant upside potential. It emphasizes that early stakes in companies or cryptocurrencies can function like long-dated options with substantial returns, and balancing liquidity needs with diversification is crucial to avoid prematurely cashing out of potential multi-bagger winners.

10/15/2026, 8:50 PM • The Motley Fool

iPhone Duo Preorders Begin Friday. Is Apple’s First Foldable Phone Reason Alone to Buy the Stock?

Apple's iPhone Duo foldable phone launches Friday at $1,999, likely appealing primarily to existing Apple customers rather than Android switchers. While sales could reach 5-10 million units annually, the real growth opportunity lies in Apple's expanding connected home ecosystem with new affordable devices like HomeView ($299) and HomePod mini 2 ($149), which could strengthen customer loyalty and ecosystem lock-in.

10/15/2026, 6:37 PM • The Motley Fool

Adams Diversified Equity Fund Reports Nine Month Results

Adams Diversified Equity Fund (ADX) announced a 12.9% total return on net asset value for the first nine months of 2026, slightly outperforming the S&P 500's 12.8% return. The fund's market price returned 16.6% for the period. Net assets grew to $3.32 billion from $2.99 billion year-over-year, with the fund maintaining significant exposure to technology stocks, particularly NVIDIA (8.5%), Apple (7.4%), and Microsoft (6.2%).

10/15/2026, 5:56 PM • GlobeNewswire

These 2 Stocks Have Run Circles Around the Magnificent Seven This Year, and Wall Street Says There Is More Upside Ahead

Revolution Medicines and Oruka Therapeutics have significantly outperformed the Magnificent Seven tech stocks this year, both more than doubling. Revolution Medicines gained FDA approval for Rasonque, a pancreatic cancer treatment with blockbuster potential ($20.8B peak revenue projected). Oruka Therapeutics is developing ORKA-001 for psoriasis with promising Phase 2 results and convenient once-yearly dosing. While Wall Street sees substantial upside (36% for RVMD, 95% for ORKA), both stocks carry significant risk due to clinical uncertainty and limited approval history.

10/15/2026, 3:14 PM • The Motley Fool

The Dividend Divide: Pure Dividend Strategy ETF Meets Tech-Driven Growth ETF

iShares Core High Dividend ETF (HDV) and Fidelity High Dividend ETF (FDVV) offer contrasting approaches to dividend investing. HDV emphasizes defensive sectors like energy and staples with lower volatility and a 0.08% expense ratio, while FDVV incorporates tech exposure with higher growth potential but greater volatility and a 0.15% expense ratio. HDV has delivered 12.8% CAGR since 2021 with a 2.9% yield, while FDVV achieved 13.5% CAGR with a 2.8% yield. The choice depends on whether investors prioritize conservative income or growth-oriented dividend strategies.

10/15/2026, 1:31 PM • The Motley Fool